BUREAU DE LA PCR : revenue, balance sheet and financial ratios

BUREAU DE LA PCR is a French company founded 17 years ago, specialized in the sector Activités spécialisées, scientifiques et techniques diverses. Based in SAINT-PAUL-TROIS-CHATEAUX (26130), this company of category PME shows in 2020 a revenue of 2.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - BUREAU DE LA PCR (SIREN 511220782)
Indicator 2024 2023 2020 2019 2018 2016 2015
Revenue N/C N/C 2 203 914 € 2 235 306 € 1 890 581 € 1 560 571 € 1 463 904 €
Net income 658 917 € 371 207 € 140 848 € 208 973 € 207 052 € 186 184 € 264 627 €
EBITDA N/C N/C 274 062 € 385 993 € 293 220 € 337 908 € 413 257 €
Net margin N/C N/C 6.4% 9.3% 11.0% 11.9% 18.1%

Revenue and income statement

In 2024, BUREAU DE LA PCR generates positive net income of 659 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2024: 265 k€ -> 659 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

658 917 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 72%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 38%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

71.508%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

37.557%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

51.4%

Solvency indicators evolution
BUREAU DE LA PCR

Sector positioning

Debt ratio
71.51 2024
2020
2023
2024
Q1: 0.0
Med: 4.67
Q3: 40.89
Average

In 2024, the debt ratio of BUREAU DE LA PCR (71.51) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
37.56% 2024
2020
2023
2024
Q1: 4.58%
Med: 32.74%
Q3: 63.16%
Good +20 pts over 3 years

In 2024, the financial autonomy of BUREAU DE LA PCR (37.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
2.25 years 2020
2020
Q1: 0.0 years
Med: 0.0 years
Q3: 0.57 years
Average

In 2020, the repayment capacity of BUREAU DE LA PCR (2.25) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 229.41. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

229.415

Liquidity indicators evolution
BUREAU DE LA PCR

Sector positioning

Liquidity ratio
229.41 2024
2020
2023
2024
Q1: 144.63
Med: 259.05
Q3: 521.3
Average +19 pts over 3 years

In 2024, the liquidity ratio of BUREAU DE LA PCR (229.41) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
0.0x 2020
2020
Q1: 0.0x
Med: 0.0x
Q3: 0.21x
Average

In 2020, the interest coverage of BUREAU DE LA PCR (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
BUREAU DE LA PCR

Positioning of BUREAU DE LA PCR in its sector

Comparison with sector Activités spécialisées, scientifiques et techniques diverses

Valuation estimate

Based on 98 transactions of similar company sales (all years), the value of BUREAU DE LA PCR is estimated at 3 198 086 € (range 643 911€ - 5 379 626€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
98 tx
643k€ 3198k€ 5379k€
3 198 086 € Range: 643 911€ - 5 379 626€
NAF 5 all-time

Valuation method used

Net Income Multiple
658 917 € × 4.9x = 3 198 087 €
Range: 643 911€ - 5 379 626€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 98 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités spécialisées, scientifiques et techniques diverses)

Compare BUREAU DE LA PCR with other companies in the same sector:

Voir toutes les statistiques du secteur Activités spécialisées, scientifiques et techniques diverses

Frequently asked questions about BUREAU DE LA PCR

What is the revenue of BUREAU DE LA PCR ?

The revenue of BUREAU DE LA PCR in 2020 is 2.2 M€.

Is BUREAU DE LA PCR profitable?

Yes, BUREAU DE LA PCR generated a net profit of 659 k€ in 2024.

Where is the headquarters of BUREAU DE LA PCR ?

The headquarters of BUREAU DE LA PCR is located in SAINT-PAUL-TROIS-CHATEAUX (26130), in the department Drome.

Where to find the tax return of BUREAU DE LA PCR ?

The tax return of BUREAU DE LA PCR is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does BUREAU DE LA PCR operate?

BUREAU DE LA PCR operates in the sector Activités spécialisées, scientifiques et techniques diverses (NAF code 74.90B). See the 'Sector positioning' section above to compare the company with its competitors.